$MARK
REMARK HOLDINGS, INC. Stock $mark

$mark Overview Financials Valuation SEC Filings Company Website

2021 Q4 Form 10-K Financial Statement

#000136836522000016 Filed on March 31, 2022

Income Statement

Concept	2021 Q4	2021	2020 Q4
Revenue	$6.334M	$15.99M	$4.770M
YoY Change	32.79%	57.61%	1734.62%
Cost Of Revenue	$5.597M	$11.46M	$3.510M
YoY Change	59.46%	78.37%	1747.37%
Gross Profit	$737.0K	$4.535M	$1.260M
YoY Change	-41.51%	21.81%	1700.0%
Gross Profit Margin	11.64%	28.36%	26.42%
Selling, General & Admin	$2.138M	$15.09M	$4.410M
YoY Change	-51.52%	34.55%	-31.2%
% of Gross Profit	290.09%	332.77%	350.0%
Research & Development	$1.202M	$4.692M	$1.280M
YoY Change	-6.09%	13.28%	93.94%
% of Gross Profit	163.09%	103.46%	101.59%
Depreciation & Amortization	$41.00K	$191.0K	$80.00K
YoY Change	-48.75%	-37.99%	-52.94%
% of Gross Profit	5.56%	4.21%	6.35%
Operating Expenses	$1.851M	$19.78M	$5.770M
YoY Change	-67.92%	28.81%	-20.41%
Operating Profit	-$1.114M	-$13.91M	-$4.510M
YoY Change	-75.3%	-2.36%	-37.19%
Interest Expense	-$36.53M	$2.308M	-$50.00K
YoY Change	72960.0%	71.98%	-89.58%
% of Operating Profit
Other Income/Expense, Net	-$608.0K	$41.39M	-$980.0K
YoY Change	-37.96%	7291.07%	-177.17%
Pretax Income	-$38.25M	$27.48M	-$5.860M
YoY Change	552.76%	-300.81%	-35.25%
Income Tax	$0.00	$9.000K
% Of Pretax Income		0.03%
Net Earnings	-$38.25M	$27.47M	-$5.860M
YoY Change	552.76%	-300.75%	-35.25%
Net Earnings / Revenue	-603.92%	171.81%	-122.85%
Basic Earnings Per Share		$0.27
Diluted Earnings Per Share	-$363.7K	$0.27	-$58.84K
COMMON SHARES
Basic Shares Outstanding	105.2M shares	101.4M shares	99.51M shares
Diluted Shares Outstanding		101.7M shares

Balance Sheet

Concept	2021 Q4	2021	2020 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$56.54M	$56.54M	$900.0K
YoY Change	6181.78%	6181.78%	200.0%
Cash & Equivalents	$14.19M	$14.19M	$854.0K
Short-Term Investments	$42.35M	$42.35M
Other Short-Term Assets	$6.000K	$2.374M	$108.0K
YoY Change	-94.44%	13.05%	-60.15%
Inventory	$1.346M	$1.346M	$874.0K
Prepaid Expenses	$1.558M		$1.877M
Receivables	$10.27M	$10.27M	$5.027M
Other Receivables	$9.000K	$3.989M	$0.00
Total Short-Term Assets	$74.51M	$74.51M	$8.798M
YoY Change	746.92%	746.73%	28.27%
LONG-TERM ASSETS
Property, Plant & Equipment	$357.0K	$551.0K	$321.0K
YoY Change	11.21%	-31.13%	-5.87%
Goodwill
YoY Change
Intangibles			$0.00
YoY Change			-100.0%
Long-Term Investments	$0.00	$0.00	$1.000M
YoY Change	-100.0%	-100.0%	-47.37%
Other Assets	$440.0K	$440.0K	$670.0K
YoY Change	-34.33%	-37.14%	-18.69%
Total Long-Term Assets	$991.0K	$991.0K	$2.513M
YoY Change	-60.57%	-60.36%	-68.46%
TOTAL ASSETS
Total Short-Term Assets	$74.51M	$74.51M	$8.798M
Total Long-Term Assets	$991.0K	$991.0K	$2.513M
Total Assets	$75.50M	$75.50M	$11.31M
YoY Change	567.52%	568.17%	-23.71%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$10.09M	$10.09M	$8.589M
YoY Change	17.52%	17.37%	5.7%
Accrued Expenses	$5.963M	$3.505M	$6.660M
YoY Change	-10.47%	29.81%	-53.51%
Deferred Revenue	$576.0K		$310.0K
YoY Change	85.81%		-0.96%
Short-Term Debt	$27.81M	$27.81M	$0.00
YoY Change		1754.07%	-100.0%
Long-Term Debt Due			$0.00
YoY Change			-100.0%
Total Short-Term Liabilities	$44.44M	$44.44M	$17.06M
YoY Change	160.53%	159.91%	-54.86%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$1.425M
YoY Change	-100.0%	-100.0%
Other Long-Term Liabilities	$25.00K	$25.00K	$1.900M
YoY Change	-98.68%	-98.68%
Total Long-Term Liabilities	$0.00	$25.00K	$1.425M
YoY Change	-100.0%	-99.24%
TOTAL LIABILITIES
Total Short-Term Liabilities	$44.44M	$44.44M	$17.06M
Total Long-Term Liabilities	$0.00	$25.00K	$1.425M
Total Liabilities	$44.47M	$44.47M	$20.40M
YoY Change	117.95%	117.99%	-52.05%
SHAREHOLDERS EQUITY
Retained Earnings	-$333.0M		-$360.5M
YoY Change	-7.62%		3.95%
Common Stock	$105.0K		$100.0K
YoY Change	5.0%		96.08%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$31.03M	$31.03M	-$9.092M
YoY Change
Total Liabilities & Shareholders Equity	$75.50M	$75.50M	$11.31M
YoY Change	567.52%	568.17%	-23.71%

Cashflow Statement

Concept	2021 Q4	2021	2020 Q4
OPERATING ACTIVITIES
Net Income	-$38.25M	$27.47M	-$5.860M
YoY Change	552.76%	-300.75%	-35.25%
Depreciation, Depletion And Amortization	$41.00K	$191.0K	$80.00K
YoY Change	-48.75%	-37.99%	-52.94%
Cash From Operating Activities	-$10.06M	-$20.17M	-$3.520M
YoY Change	185.71%	11.79%	87.23%
INVESTING ACTIVITIES
Capital Expenditures	-$68.00K	$223.0K	-$120.0K
YoY Change	-43.33%	-23.1%	1100.0%
Acquisitions
YoY Change
Other Investing Activities	$0.00	$2.322M	$1.410M
YoY Change	-100.0%
Cash From Investing Activities	-$68.00K	$2.099M	$1.290M
YoY Change	-105.27%	-823.79%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net		$5.692M
YoY Change		-82.29%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	21.14M	$31.41M	990.0K
YoY Change	2035.76%	66.01%	-34.0%
NET CHANGE
Cash From Operating Activities	-10.06M	-$20.17M	-3.520M
Cash From Investing Activities	-68.00K	$2.099M	1.290M
Cash From Financing Activities	21.14M	$31.41M	990.0K
Net Change In Cash	11.02M	$13.33M	-1.240M
YoY Change	-988.63%	2190.89%	226.32%
FREE CASH FLOW
Cash From Operating Activities	-$10.06M	-$20.17M	-$3.520M
Capital Expenditures	-$68.00K	$223.0K	-$120.0K
Free Cash Flow	-$9.989M	-$20.40M	-$3.400M
YoY Change	193.79%	11.23%	81.82%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2021	dei	Document Annual Report DocumentAnnualReport	true
CY2021	dei	Document Transition Report DocumentTransitionReport	false
CY2021	dei	Entity Central Index Key EntityCentralIndexKey	0001368365
CY2021	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2021
CY2021	dei	Security12b Title Security12bTitle	Common Stock, $0.001 par value per share
CY2021	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2020Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	6660000	USD
CY2021	dei	Trading Symbol TradingSymbol	MARK
CY2021	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2021	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2021	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2021	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2021	dei	Amendment Flag AmendmentFlag	false
CY2021Q4	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#AccruedLiabilitiesCurrent
CY2020Q4	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#AccruedLiabilitiesCurrent
CY2021	dei	Document Type DocumentType	10-K
CY2021	dei	Document Period End Date DocumentPeriodEndDate	2021-12-31
CY2021	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2021	dei	Entity File Number EntityFileNumber	001-33720
CY2021	dei	Entity Registrant Name EntityRegistrantName	Remark Holdings, Inc.
CY2021	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2021	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	33-1135689
CY2021	dei	Entity Address Address Line1 EntityAddressAddressLine1	800 S. Commerce St.
CY2021	dei	Entity Address City Or Town EntityAddressCityOrTown	Las Vegas
CY2021	dei	Entity Address State Or Province EntityAddressStateOrProvince	NV
CY2021	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	89106
CY2021	dei	City Area Code CityAreaCode	702
CY2021	dei	Local Phone Number LocalPhoneNumber	701-9514
CY2021	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2021Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	42349000	USD
CY2020Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	0	USD
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	14187000	USD
CY2021	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2021	dei	Entity Small Business EntitySmallBusiness	true
CY2021	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2021	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2021	dei	Entity Shell Company EntityShellCompany	false
CY2021Q2	dei	Entity Public Float EntityPublicFloat	175000000	USD
CY2022Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	105157769	shares
CY2021Q3	us-gaap	Investment Owned Balance Shares InvestmentOwnedBalanceShares	9400000	shares
CY2021	dei	Auditor Firm AuditorFirmId	572
CY2021	dei	Auditor Name AuditorName	Weinberg & Company, P.A.
CY2021	dei	Auditor Location AuditorLocation	Los Angeles, California
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	854000	USD
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	10267000	USD
CY2020Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	5027000	USD
CY2021Q4	us-gaap	Inventory Net InventoryNet	1346000	USD
CY2020Q4	us-gaap	Inventory Net InventoryNet	874000	USD
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2020Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	6363000	USD
CY2020Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	2043000	USD
CY2021Q4	us-gaap	Assets Current AssetsCurrent	74512000	USD
CY2020Q4	us-gaap	Assets Current AssetsCurrent	8798000	USD
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	357000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	321000	USD
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	194000	USD
CY2020Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	492000	USD
CY2021Q4	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	0	USD
CY2020Q4	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	1030000	USD
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	440000	USD
CY2020Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	670000	USD
CY2021Q4	us-gaap	Assets Assets	75503000	USD
CY2020Q4	us-gaap	Assets Assets	11311000	USD
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	10094000	USD
CY2020Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	8589000	USD
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	5963000	USD
CY2021Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	576000	USD
CY2020Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	310000	USD
CY2021Q4	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	2189000	USD
CY2020Q4	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	0	USD
CY2021Q4	us-gaap	Short Term Non Bank Loans And Notes Payable ShortTermNonBankLoansAndNotesPayable	27811000	USD
CY2020Q4	us-gaap	Short Term Non Bank Loans And Notes Payable ShortTermNonBankLoansAndNotesPayable	1500000	USD
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	44444000	USD
CY2020Q4	us-gaap	Liabilities Current LiabilitiesCurrent	17059000	USD
CY2021Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	0	USD
CY2020Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	1425000	USD
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	25000	USD
CY2020Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	194000	USD
CY2021Q4	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	0	USD
CY2020Q4	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	1725000	USD
CY2021Q4	us-gaap	Liabilities Liabilities	44469000	USD
CY2020Q4	us-gaap	Liabilities Liabilities	20403000	USD
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2020Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2020Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2020Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2020Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2021Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2020Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2020Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	175000000	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	175000000	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	105157769	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	105157769	shares
CY2020Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	99505041	shares
CY2020Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	99505041	shares
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	105000	USD
CY2020Q4	us-gaap	Common Stock Value CommonStockValue	100000	USD
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	364239000	USD
CY2020Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	351546000	USD
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-270000	USD
CY2020Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-226000	USD
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-333040000	USD
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-360512000	USD
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	31034000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	-9092000	USD
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	75503000	USD
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	11311000	USD
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	15990000	USD
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	10145000	USD
CY2021	us-gaap	Cost Of Revenue CostOfRevenue	11455000	USD
CY2020	us-gaap	Cost Of Revenue CostOfRevenue	6422000	USD
CY2021	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	971000	USD
CY2020	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1848000	USD
CY2021	mark	Recovery Of Marketing Expense RecoveryOfMarketingExpense	-1530000	USD
CY2020	mark	Recovery Of Marketing Expense RecoveryOfMarketingExpense	1530000	USD
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	4692000	USD
CY2020	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	4142000	USD
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	14120000	USD
CY2020	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	9368000	USD
CY2021	us-gaap	Depreciation And Amortization DepreciationAndAmortization	191000	USD
CY2020	us-gaap	Depreciation And Amortization DepreciationAndAmortization	308000	USD
CY2021	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	USD
CY2020	us-gaap	Asset Impairment Charges AssetImpairmentCharges	772000	USD
CY2021	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	0	USD
CY2020	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	0	USD
CY2021	us-gaap	Costs And Expenses CostsAndExpenses	29899000	USD
CY2020	us-gaap	Costs And Expenses CostsAndExpenses	24390000	USD
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-13909000	USD
CY2020	us-gaap	Operating Income Loss OperatingIncomeLoss	-14245000	USD
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	-27728000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-13685000	USD
CY2021	us-gaap	Interest Expense InterestExpense	2308000	USD
CY2020	us-gaap	Interest Expense InterestExpense	1342000	USD
CY2021	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-592000	USD
CY2020	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	0	USD
CY2021	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	123000	USD
CY2020	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-1610000	USD
CY2021	us-gaap	Gain Loss On Investments GainLossOnInvestments	43642000	USD
CY2020	us-gaap	Gain Loss On Investments GainLossOnInvestments	0	USD
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	425000	USD
CY2020	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
CY2021	us-gaap	Gain Loss On Termination Of Lease GainLossOnTerminationOfLease	0	USD
CY2020	us-gaap	Gain Loss On Termination Of Lease GainLossOnTerminationOfLease	3582000	USD
CY2021	mark	Other Nonoperating Gain Loss OtherNonoperatingGainLoss	100000	USD
CY2020	mark	Other Nonoperating Gain Loss OtherNonoperatingGainLoss	-70000	USD
CY2021	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	41390000	USD
CY2020	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	560000	USD
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	27481000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-13685000	USD
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	9000	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2021	us-gaap	Net Income Loss NetIncomeLoss	27472000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-13685000	USD
CY2021	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-44000	USD
CY2020	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	1000	USD
CY2021	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	27428000	USD
CY2020	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-13684000	USD
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	101362000	shares
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	85578000	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	101719000	shares
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	85578000	shares
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.27
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.16
CY2020	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	160000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	-9092000	USD
CY2021	us-gaap	Net Income Loss NetIncomeLoss	27472000	USD
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.27
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.16
CY2021	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	4300000	USD
CY2021	mark	Stock Issued During Period Value New Issues Excluding Acquisitions StockIssuedDuringPeriodValueNewIssuesExcludingAcquisitions	4614000	USD
CY2021	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	1077000	USD
CY2021	mark	Stock Issued During Period Value Conversion Of Convertible Debt StockIssuedDuringPeriodValueConversionOfConvertibleDebt	1105000	USD
CY2020	mark	Stock Issued During Period Value New Issues Excluding Acquisitions StockIssuedDuringPeriodValueNewIssuesExcludingAcquisitions	32030000	USD
CY2020	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	130000	USD
CY2020	us-gaap	Stockholders Equity Other StockholdersEquityOther	-1000	USD
CY2021	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	1602000	USD
CY2021	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-44000	USD
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	31034000	USD
CY2021	us-gaap	Net Income Loss NetIncomeLoss	27472000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-13685000	USD
CY2021	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	123000	USD
CY2020	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-1610000	USD
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	191000	USD
CY2020	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	308000	USD
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	4060000	USD
CY2020	us-gaap	Share Based Compensation ShareBasedCompensation	797000	USD
CY2021	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	880000	USD
CY2020	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	0	USD
CY2021	us-gaap	Gain Loss On Termination Of Lease GainLossOnTerminationOfLease	0	USD
CY2020	us-gaap	Gain Loss On Termination Of Lease GainLossOnTerminationOfLease	3582000	USD
CY2021	us-gaap	Gain Loss On Investments GainLossOnInvestments	43642000	USD
CY2020	us-gaap	Gain Loss On Investments GainLossOnInvestments	0	USD
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	425000	USD
CY2020	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
CY2021	us-gaap	Gain Loss On Sale Of Other Assets GainLossOnSaleOfOtherAssets	0	USD
CY2020	us-gaap	Gain Loss On Sale Of Other Assets GainLossOnSaleOfOtherAssets	-77000	USD
CY2021	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	0	USD
CY2020	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	1425000	USD
CY2020	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	772000	USD
CY2021	mark	Financing Cost For Conversion Of Notes Payable To Common Stock FinancingCostForConversionOfNotesPayableToCommonStock	44000	USD
CY2020	mark	Financing Cost For Conversion Of Notes Payable To Common Stock FinancingCostForConversionOfNotesPayableToCommonStock	0	USD
CY2021	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	297000	USD
CY2020	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	24000	USD
CY2021	us-gaap	Proceeds From Other Operating Activities ProceedsFromOtherOperatingActivities	30000	USD
CY2020	us-gaap	Proceeds From Other Operating Activities ProceedsFromOtherOperatingActivities	269000	USD
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	5733000	USD
CY2020	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	2849000	USD
CY2021	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	473000	USD
CY2020	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	874000	USD
CY2021	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	4120000	USD
CY2020	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-95000	USD
CY2021	mark	Increase Decrease In Operating Lease Right Of Use Asset IncreaseDecreaseInOperatingLeaseRightOfUseAsset	-293000	USD
CY2020	mark	Increase Decrease In Operating Lease Right Of Use Asset IncreaseDecreaseInOperatingLeaseRightOfUseAsset	-73000	USD
CY2021	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	967000	USD
CY2020	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-920000	USD
CY2021	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	277000	USD
CY2020	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-27000	USD
CY2021	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-169000	USD
CY2020	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-135000	USD
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-20174000	USD
CY2020	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-18047000	USD
CY2021	us-gaap	Proceeds From Sale Maturity And Collections Of Investments ProceedsFromSaleMaturityAndCollectionsOfInvestments	2322000	USD
CY2020	us-gaap	Proceeds From Sale Maturity And Collections Of Investments ProceedsFromSaleMaturityAndCollectionsOfInvestments	0	USD
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	223000	USD
CY2020	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	290000	USD
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	2099000	USD
CY2020	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-290000	USD
CY2021	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	5692000	USD
CY2020	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	32135000	USD
CY2021	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	32216000	USD
CY2021	us-gaap	Proceeds From Repayments Of Debt ProceedsFromRepaymentsOfDebt	-6500000	USD
CY2020	us-gaap	Proceeds From Repayments Of Debt ProceedsFromRepaymentsOfDebt	-13781000	USD
CY2021	us-gaap	Payment For Contingent Consideration Liability Financing Activities PaymentForContingentConsiderationLiabilityFinancingActivities	0	USD
CY2020	us-gaap	Payment For Contingent Consideration Liability Financing Activities PaymentForContingentConsiderationLiabilityFinancingActivities	860000	USD
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	31408000	USD
CY2020	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	18919000	USD
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	13333000	USD
CY2020	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	582000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	854000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	272000	USD
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	14187000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	854000	USD
CY2021	us-gaap	Interest Paid Net InterestPaidNet	1414000	USD
CY2020	us-gaap	Interest Paid Net InterestPaidNet	0	USD
CY2021	mark	Non Cash Or Part Non Cash Issuance Of Common Stock NonCashOrPartNonCashIssuanceOfCommonStock	1105000	USD
CY2020	mark	Non Cash Or Part Non Cash Issuance Of Common Stock NonCashOrPartNonCashIssuanceOfCommonStock	0	USD
CY2021	mark	Noncash Or Part Noncash Reclassifications Of Warrant Liability To Equity NoncashOrPartNoncashReclassificationsOfWarrantLiabilityToEquity	1602000	USD
CY2020	mark	Noncash Or Part Noncash Reclassifications Of Warrant Liability To Equity NoncashOrPartNoncashReclassificationsOfWarrantLiabilityToEquity	0	USD
CY2021	mark	Noncash Or Part Noncash Reclassifications Of Investment To Marketable Securities NoncashOrPartNoncashReclassificationsOfInvestmentToMarketableSecurities	1030000	USD
CY2020	mark	Noncash Or Part Noncash Reclassifications Of Investment To Marketable Securities NoncashOrPartNoncashReclassificationsOfInvestmentToMarketableSecurities	0	USD
CY2021	mark	Off Setting Of Other Receivables Against Other Current Liabilities OffSettingOfOtherReceivablesAgainstOtherCurrentLiabilities	0	USD
CY2020	mark	Off Setting Of Other Receivables Against Other Current Liabilities OffSettingOfOtherReceivablesAgainstOtherCurrentLiabilities	3060000	USD
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-333000000	USD
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-20200000	USD
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	14200000	USD
CY2021	us-gaap	Use Of Estimates UseOfEstimates	<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We prepare our consolidated financial statements in conformity with GAAP. While preparing our financial statements, we make estimates and assumptions that affect amounts reported and disclosed in the consolidated financial statements and accompanying notes. Accordingly, actual results could differ from those estimates. On an ongoing basis, we evaluate our </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">estimates, including those related to accounts receivable, share-based compensation, deferred income taxes, and inventory reserve, among other items.</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The impact of the COVID-19 pandemic continues to unfold. As a result, many of our estimates and assumptions required increased judgment and carry a higher degree of variability and volatility. As events continue to evolve and additional information becomes available, our estimates may change materially in future periods.</span></div>
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	14187000	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	854000	USD
CY2021Q4	us-gaap	Cash Uninsured Amount CashUninsuredAmount	13000000	USD
CY2021	mark	Contract With Customer Term Of Contract ContractWithCustomerTermOfContract	P1Y
CY2021Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	1000000	USD
CY2020	us-gaap	Advertising Expense AdvertisingExpense	200000	USD
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	101362000	shares
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	85578000	shares
CY2021	mark	Incremental Shares Attributable To Assumes Exercise Of In The Money Stock Options IncrementalSharesAttributableToAssumesExerciseOfInTheMoneyStockOptions	357000	shares
CY2020	mark	Incremental Shares Attributable To Assumes Exercise Of In The Money Stock Options IncrementalSharesAttributableToAssumesExerciseOfInTheMoneyStockOptions	0	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	101719000	shares
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	85578000	shares
CY2021	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1	segment
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	15990000	USD
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	10145000	USD
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	15990000	USD
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	10145000	USD
CY2020	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	0	USD
CY2021	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	0	USD
CY2021	us-gaap	Contract With Customer Performance Obligation Satisfied In Previous Period ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod	0	USD
CY2020	us-gaap	Contract With Customer Performance Obligation Satisfied In Previous Period ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod	0	USD
	mark	Warrant Or Right Warrants Issued In Transaction WarrantOrRightWarrantsIssuedInTransaction	40000	shares
CY2021Q4	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	11551000	USD
CY2020Q4	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	5988000	USD
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	1284000	USD
CY2020Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	961000	USD
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	10267000	USD
CY2020Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	5027000	USD
CY2021Q3	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders	2300000	USD
CY2021Q3	us-gaap	Investment Owned Balance Shares InvestmentOwnedBalanceShares	9400000	shares
CY2021	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	2322000	USD
CY2021	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	41320000	USD
CY2021	us-gaap	Gain Loss On Investments GainLossOnInvestments	43642000	USD
CY2021Q4	us-gaap	Due From Related Parties Current DueFromRelatedPartiesCurrent	3980000	USD
CY2020Q4	us-gaap	Due From Related Parties Current DueFromRelatedPartiesCurrent	0	USD
CY2021Q4	us-gaap	Other Receivables Gross Current OtherReceivablesGrossCurrent	9000	USD
CY2020Q4	us-gaap	Other Receivables Gross Current OtherReceivablesGrossCurrent	8000	USD
CY2021Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	1558000	USD
CY2020Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	1877000	USD
CY2021Q4	us-gaap	Deposits Assets Current DepositsAssetsCurrent	221000	USD
CY2020Q4	us-gaap	Deposits Assets Current DepositsAssetsCurrent	50000	USD
CY2021Q4	us-gaap	Other Assets Current OtherAssetsCurrent	595000	USD
CY2020Q4	us-gaap	Other Assets Current OtherAssetsCurrent	108000	USD
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	6363000	USD
CY2020Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	2043000	USD
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	6554000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	6319000	USD
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	6197000	USD
CY2020Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	5998000	USD
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	357000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	321000	USD
CY2021	mark	Depreciation And Amortization Expense Excluding Amortization Of Intangible Assets DepreciationAndAmortizationExpenseExcludingAmortizationOfIntangibleAssets	200000	USD
CY2020	mark	Depreciation And Amortization Expense Excluding Amortization Of Intangible Assets DepreciationAndAmortizationExpenseExcludingAmortizationOfIntangibleAssets	200000	USD
CY2021	us-gaap	Operating Lease Cost OperatingLeaseCost	304000	USD
CY2020	us-gaap	Operating Lease Cost OperatingLeaseCost	640000	USD
CY2021	us-gaap	Short Term Lease Cost ShortTermLeaseCost	982000	USD
CY2020	us-gaap	Short Term Lease Cost ShortTermLeaseCost	291000	USD
CY2021	us-gaap	Lease Cost LeaseCost	1286000	USD
CY2020	us-gaap	Lease Cost LeaseCost	931000	USD
CY2021	us-gaap	Operating Lease Payments OperatingLeasePayments	200000	USD
CY2020	us-gaap	Operating Lease Payments OperatingLeasePayments	600000	USD
CY2021Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P12M
CY2021Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.13
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Rolling Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths	201000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due In Rolling Year Two LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo	25000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	226000	USD
CY2021Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	212000	USD
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	187000	USD
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	25000	USD
CY2021Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	212000	USD
CY2020Q2	us-gaap	Loss Contingency Damages Sought Value LossContingencyDamagesSoughtValue	1100000	USD
CY2020	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	-96000	USD
CY2021	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	5771000	USD
CY2020	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-2874000	USD
CY2021	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	-5241000	USD
CY2020	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	1670000	USD
CY2021	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	-26000	USD
CY2020	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	338000	USD
CY2021	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate	327000	USD
CY2020	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate	1014000	USD
CY2021	us-gaap	Income Tax Reconciliation Tax Credits Research IncomeTaxReconciliationTaxCreditsResearch	210000	USD
CY2020	us-gaap	Income Tax Reconciliation Tax Credits Research IncomeTaxReconciliationTaxCreditsResearch	202000	USD
CY2021	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	68000	USD
CY2021	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	-331000	USD
CY2020	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	155000	USD
CY2021	mark	Effective Income Tax Rate Reconciliation Increase Decrease In Deferred Assets Amount EffectiveIncomeTaxRateReconciliationIncreaseDecreaseInDeferredAssetsAmount	99000	USD
CY2020	mark	Effective Income Tax Rate Reconciliation Increase Decrease In Deferred Assets Amount EffectiveIncomeTaxRateReconciliationIncreaseDecreaseInDeferredAssetsAmount	86000	USD
CY2021	us-gaap	Income Tax Reconciliation Other Reconciling Items IncomeTaxReconciliationOtherReconcilingItems	-466000	USD
CY2020	us-gaap	Income Tax Reconciliation Other Reconciling Items IncomeTaxReconciliationOtherReconcilingItems	-91000	USD
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	9000	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	28036000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-11289000	USD
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-555000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-2396000	USD
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	27481000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-13685000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	43375000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	41061000	USD
CY2021Q4	mark	Deferred Tax Assets Amortization DeferredTaxAssetsAmortization	1979000	USD
CY2020Q4	mark	Deferred Tax Assets Amortization DeferredTaxAssetsAmortization	2167000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	7423000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	6876000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	3503000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	3000000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	56280000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	53104000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	47857000	USD
CY2020Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	0	USD
CY2020Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	USD
CY2020Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	53117000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	8423000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	-13000	USD
CY2021Q4	us-gaap	Deferred Tax Liabilities Tax Deferred Income DeferredTaxLiabilitiesTaxDeferredIncome	8444000	USD
CY2020Q4	us-gaap	Deferred Tax Liabilities Tax Deferred Income DeferredTaxLiabilitiesTaxDeferredIncome	0	USD
CY2021Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	-21000	USD
CY2020Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	-13000	USD
CY2021Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	8423000	USD
CY2020Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	-13000	USD
CY2021Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	0	USD
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	USD
CY2021Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	821000	USD
CY2020Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	1151000	USD
CY2021Q4	us-gaap	Interest Payable Current InterestPayableCurrent	385000	USD
CY2020Q4	us-gaap	Interest Payable Current InterestPayableCurrent	485000	USD
CY2021Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1673000	USD
CY2020Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	721000	USD
CY2021Q4	us-gaap	Accounts Payable Other Current AccountsPayableOtherCurrent	2324000	USD
CY2020Q4	us-gaap	Accounts Payable Other Current AccountsPayableOtherCurrent	3048000	USD
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	187000	USD
CY2020Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	382000	USD
CY2021Q4	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	439000	USD
CY2020Q4	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	679000	USD
CY2021Q4	us-gaap	Other Sundry Liabilities Current OtherSundryLiabilitiesCurrent	134000	USD
CY2020Q4	us-gaap	Other Sundry Liabilities Current OtherSundryLiabilitiesCurrent	194000	USD
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	5963000	USD
CY2020Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	6660000	USD
CY2021Q4	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	2189000	USD
CY2020Q4	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	0	USD
CY2021Q4	us-gaap	Notes Payable NotesPayable	27811000	USD
CY2020Q4	us-gaap	Notes Payable NotesPayable	1500000	USD
CY2021Q3	us-gaap	Loss Contingency Estimate Of Possible Loss LossContingencyEstimateOfPossibleLoss	600000	USD
CY2021Q3	us-gaap	Loss Contingency Damages Sought Value LossContingencyDamagesSoughtValue	1000000	USD
CY2020	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	399188	shares
CY2020	mark	Share Based Compensation Arrangement By Share Based Payment Award Options Exercised Aggregate Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedAggregateWeightedAverageGrantDateFairValue	168000	USD
CY2019Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	610187	shares
CY2019Q4	mark	Sharebased Compensation Arrangementby Sharebased Payment Award Options Nonvested Aggregate Weighted Average Grant Date Fair Value SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsNonvestedAggregateWeightedAverageGrantDateFairValue	241000	USD
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares	50124	shares
CY2020	mark	Sharebased Compensation Arrangementby Sharebased Payment Award Options Nonvested Options Forfeited Aggregate Weighted Average Grant Date Fair Value SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedAggregateWeightedAverageGrantDateFairValue	53000	USD
CY2020Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	160875	shares
CY2020Q4	mark	Sharebased Compensation Arrangementby Sharebased Payment Award Options Nonvested Aggregate Weighted Average Grant Date Fair Value SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsNonvestedAggregateWeightedAverageGrantDateFairValue	68000	USD
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	5463500	shares
CY2021	mark	Share Based Compensation Arrangement By Share Based Payment Award Options Nonvested Options Granted Aggregate Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedOptionsGrantedAggregateWeightedAverageGrantDateFairValue	4972000	USD
CY2021	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	3547875	shares
CY2021	mark	Share Based Compensation Arrangement By Share Based Payment Award Options Exercised Aggregate Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedAggregateWeightedAverageGrantDateFairValue	3512000	USD
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares	14000	shares
CY2021	mark	Sharebased Compensation Arrangementby Sharebased Payment Award Options Nonvested Options Forfeited Aggregate Weighted Average Grant Date Fair Value SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedAggregateWeightedAverageGrantDateFairValue	17000	USD
CY2021Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	2062500	shares
CY2021Q4	mark	Sharebased Compensation Arrangementby Sharebased Payment Award Options Nonvested Aggregate Weighted Average Grant Date Fair Value SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsNonvestedAggregateWeightedAverageGrantDateFairValue	2063000	USD
CY2021	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	1100000	USD
CY2020	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	100000	USD
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	1000000	USD
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	100000	USD
CY2021Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	175000000	shares
CY2020Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	6300000	shares
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	4060000	USD
CY2020	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	797000	USD
CY2021Q4	us-gaap	Equity Method Investments EquityMethodInvestments	0	USD
CY2021Q4	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	0	USD
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	14187000	USD
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	10267000	USD
CY2021Q4	us-gaap	Inventory Net InventoryNet	1346000	USD
CY2021Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	42349000	USD
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	6363000	USD
CY2021Q4	us-gaap	Assets Current AssetsCurrent	74512000	USD
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	357000	USD
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	194000	USD
CY2021Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	576000	USD
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	440000	USD
CY2021Q4	us-gaap	Assets Assets	75503000	USD
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	10094000	USD
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	5963000	USD
CY2021Q4	us-gaap	Short Term Non Bank Loans And Notes Payable ShortTermNonBankLoansAndNotesPayable	27811000	USD
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	44444000	USD
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	25000	USD
CY2021Q4	us-gaap	Liabilities Liabilities	44469000	USD
CY2021Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	105000	USD
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	364239000	USD
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-270000	USD
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-333040000	USD
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	31034000	USD
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	75503000	USD
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	15990000	USD
CY2021	us-gaap	Cost Of Revenue CostOfRevenue	11455000	USD
CY2021	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	971000	USD
CY2021	mark	Recovery Of Marketing Expense RecoveryOfMarketingExpense	-1530000	USD
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	4692000	USD
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	14120000	USD
CY2021	us-gaap	Depreciation And Amortization DepreciationAndAmortization	191000	USD
CY2021	us-gaap	Costs And Expenses CostsAndExpenses	29899000	USD
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-13909000	USD
CY2021	us-gaap	Interest Expense InterestExpense	2308000	USD
CY2021	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-592000	USD
CY2021	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	123000	USD
CY2021	us-gaap	Gain Loss On Investments GainLossOnInvestments	43642000	USD
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	425000	USD
CY2021	us-gaap	Gain Loss On Termination Of Lease GainLossOnTerminationOfLease	0	USD
CY2021	mark	Other Nonoperating Gain Loss OtherNonoperatingGainLoss	100000	USD
CY2021	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	0	USD
CY2021	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	41390000	USD
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	27481000	USD
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	9000	USD
CY2021	us-gaap	Net Income Loss NetIncomeLoss	27472000	USD
CY2021	us-gaap	Net Income Loss NetIncomeLoss	27472000	USD
CY2021	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	123000	USD
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	191000	USD
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	4060000	USD
CY2021	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	880000	USD
CY2021	us-gaap	Gain Loss On Investments GainLossOnInvestments	43642000	USD
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	425000	USD
CY2021	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	0	USD
CY2021	mark	Financing Cost For Conversion Of Notes Payable To Common Stock FinancingCostForConversionOfNotesPayableToCommonStock	44000	USD
CY2021	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	297000	USD
CY2021	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-30000	USD
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	5733000	USD
CY2021	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	473000	USD
CY2021	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	4120000	USD
CY2021	mark	Increase Decrease In Operating Lease Right Of Use Asset IncreaseDecreaseInOperatingLeaseRightOfUseAsset	-293000	USD
CY2021	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	967000	USD
CY2021	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	277000	USD
CY2021	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-169000	USD
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-20174000	USD
CY2021	us-gaap	Proceeds From Sale Maturity And Collections Of Investments ProceedsFromSaleMaturityAndCollectionsOfInvestments	2322000	USD
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	223000	USD
CY2021	mark	Other Payments Variable Interest Entities Net OtherPaymentsVariableInterestEntitiesNet	0	USD
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	2099000	USD
CY2021	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	5692000	USD
CY2021	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	32216000	USD
CY2021	us-gaap	Proceeds From Repayments Of Debt ProceedsFromRepaymentsOfDebt	-6500000	USD
CY2021	mark	Other Proceeds Variable Interest Entities Net OtherProceedsVariableInterestEntitiesNet	0	USD
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	31408000	USD
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	13333000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	854000	USD
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	14187000	USD

Files In Submission

Name	View Source	Status
0001368365-22-000016-index-headers.html	Edgar Link	pending
0001368365-22-000016-index.html	Edgar Link	pending
0001368365-22-000016.txt	Edgar Link	pending
0001368365-22-000016-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
mark-20211231.htm	Edgar Link	pending
mark-20211231.xsd	Edgar Link	pending
mark-20211231_cal.xml	Edgar Link	unprocessable
mark-20211231_def.xml	Edgar Link	unprocessable
mark-20211231_g1.jpg	Edgar Link	pending
mark-20211231_g2.jpg	Edgar Link	pending
mark-20211231_htm.xml	Edgar Link	completed
mark-20211231_lab.xml	Edgar Link	unprocessable
mark-20211231_pre.xml	Edgar Link	unprocessable
mark_2021xform10kxex211.htm	Edgar Link	pending
mark_2021xform10kxex231.htm	Edgar Link	pending
mark_2021xformx10kxex311.htm	Edgar Link	pending
mark_2021xformx10kxex312.htm	Edgar Link	pending
mark_2021xformx10kxex32.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$MARK
REMARK HOLDINGS, INC. Stock $mark

2021 Q4 Form 10-K Financial Statement

#000136836522000016 Filed on March 31, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MARK REMARK HOLDINGS, INC. Stock $mark

2021 Q4 Form 10-K Financial Statement

#000136836522000016 Filed on March 31, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MARK
REMARK HOLDINGS, INC. Stock $mark